Focus: Artera is an AI-driven diagnostic company focused on oncology, leveraging machine learning to improve cancer detection and treatment decisions. Founded in 2014 and based in Los Altos, CA, it operates in the specialized diagnostics segment.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Stable — net +1 jobs in 30d
4 added, 3 removed. Backfill posture.
Best suited for technologists and early-stage risk-tolerant professionals seeking equity upside in AI diagnostics; limited data on financial stability or revenue trajectory raises execution risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Artera
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Artera's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo